Clinical Scorecard: At the Hart of Pathology

At a Glance

Key Highlights

• Hepatitis C has transitioned from a prevalent condition to one that is largely eradicated due to advancements in treatment.
• Molecular pathology is transforming the diagnosis of liver diseases and inflammatory GI conditions.
• Next-generation sequencing (NGS) has revealed genetic susceptibility to drug reactions.
• HLA typing helps identify patients at risk for adverse reactions to drugs and herbal supplements.
• The fellowship program fosters the next generation of leaders in GI and liver pathology.

Guideline-Based Recommendations

Diagnosis

• Utilize molecular techniques for the diagnosis of liver diseases.

Management

• Counsel patients on drug and supplement avoidance based on HLA typing results.

Monitoring & Follow-up

• Regularly assess patients for liver function and potential drug-induced injuries.

Risks

• Identify genetic predispositions to drug reactions to mitigate risks.

Patient & Prescribing Data

Individuals with liver diseases and those on medications with known hepatotoxic potential.

Understanding genetic factors can guide safer prescribing practices.

Clinical Best Practices

• Incorporate molecular pathology techniques into routine diagnostics.
• Engage in continuous education and training for fellows and residents.
• Foster collaboration and knowledge exchange within the pathology community.

References